Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty

INTRODUCTION: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of endothelial nitric oxide synthase. Asymmetric dimethylarginine may influence the process of restenosis after coronary angioplasty. The aim of the study was to determine if initial plasma ADMA level could predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Derkacz, Arkadiusz, Protasiewicz, Marcin, Poręba, Rafał, Doroszko, Adrian, Poręba, Małgorzata, Antonowicz-Juchniewicz, Jolanta, Andrzejak, Ryszard, Szuba, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258748/
https://www.ncbi.nlm.nih.gov/pubmed/22295027
http://dx.doi.org/10.5114/aoms.2011.23410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258748/
https://www.ncbi.nlm.nih.gov/pubmed/22295027
http://dx.doi.org/10.5114/aoms.2011.23410

Ejemplares similares